VEGFA and central nervous system cancer: In vitro inhibition of COX-2, mPGES-1 and CYP4A by ISL decreased FGF-2, TGF-β and VEGF production in the C6 and U87 glioma cells, accompanied with the downregulation of p-Akt expression.